Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Antiviral Agents | 45 | 2024 | 2987 | 3.830 |
Why?
|
Hepatitis B, Chronic | 16 | 2018 | 393 | 3.320 |
Why?
|
Hepatitis C, Chronic | 25 | 2024 | 1031 | 3.300 |
Why?
|
Elasticity Imaging Techniques | 10 | 2020 | 388 | 2.500 |
Why?
|
Hepatitis C | 23 | 2024 | 1591 | 2.130 |
Why?
|
Ribavirin | 16 | 2020 | 395 | 2.080 |
Why?
|
Liver Cirrhosis | 18 | 2020 | 1862 | 1.730 |
Why?
|
Interferon-alpha | 20 | 2016 | 895 | 1.660 |
Why?
|
Benzimidazoles | 6 | 2024 | 850 | 1.530 |
Why?
|
Hepatitis B | 11 | 2019 | 695 | 1.400 |
Why?
|
Fatty Liver | 10 | 2018 | 727 | 1.360 |
Why?
|
Liver Transplantation | 22 | 2023 | 2119 | 1.350 |
Why?
|
Hepacivirus | 25 | 2024 | 1379 | 1.330 |
Why?
|
Quinoxalines | 3 | 2023 | 290 | 1.330 |
Why?
|
Cholangitis, Sclerosing | 6 | 2021 | 160 | 1.310 |
Why?
|
Pyrrolidines | 2 | 2021 | 342 | 1.270 |
Why?
|
Hypertension, Portal | 5 | 2022 | 220 | 1.190 |
Why?
|
Lamivudine | 8 | 2016 | 342 | 1.170 |
Why?
|
Hepatitis B virus | 10 | 2019 | 513 | 1.140 |
Why?
|
Infectious Disease Transmission, Vertical | 11 | 2020 | 1320 | 1.100 |
Why?
|
Sulfonamides | 4 | 2024 | 1940 | 0.880 |
Why?
|
Alanine Transaminase | 13 | 2021 | 592 | 0.820 |
Why?
|
Liver | 23 | 2020 | 7475 | 0.790 |
Why?
|
Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2022 | 95 | 0.760 |
Why?
|
Child | 96 | 2024 | 77709 | 0.760 |
Why?
|
Pregnancy Complications, Infectious | 6 | 2020 | 2026 | 0.730 |
Why?
|
Polyethylene Glycols | 9 | 2016 | 1182 | 0.720 |
Why?
|
Child, Preschool | 54 | 2022 | 41005 | 0.620 |
Why?
|
Adenine | 3 | 2012 | 936 | 0.570 |
Why?
|
Vascular Malformations | 1 | 2022 | 454 | 0.560 |
Why?
|
Hepatitis B Vaccines | 6 | 2019 | 194 | 0.540 |
Why?
|
Hepatitis B e Antigens | 5 | 2015 | 133 | 0.530 |
Why?
|
Adolescent | 74 | 2024 | 85779 | 0.510 |
Why?
|
Guanine | 1 | 2015 | 274 | 0.480 |
Why?
|
Fluorenes | 3 | 2020 | 160 | 0.460 |
Why?
|
Pregnant Women | 1 | 2018 | 568 | 0.460 |
Why?
|
Liver Diseases | 7 | 2020 | 1253 | 0.450 |
Why?
|
Bile Duct Diseases | 2 | 2007 | 100 | 0.440 |
Why?
|
DNA, Viral | 8 | 2019 | 2227 | 0.440 |
Why?
|
Growth | 1 | 2014 | 376 | 0.430 |
Why?
|
Hepatitis B Surface Antigens | 7 | 2019 | 305 | 0.430 |
Why?
|
Infant | 35 | 2020 | 35134 | 0.420 |
Why?
|
Hepatitis A | 2 | 2011 | 133 | 0.420 |
Why?
|
Hepatitis, Viral, Human | 4 | 2004 | 138 | 0.410 |
Why?
|
Fissure in Ano | 2 | 2001 | 13 | 0.400 |
Why?
|
Hepatitis A Antibodies | 1 | 2011 | 18 | 0.400 |
Why?
|
Body Height | 3 | 2014 | 1578 | 0.390 |
Why?
|
Fontan Procedure | 2 | 2015 | 776 | 0.380 |
Why?
|
Carbamates | 2 | 2024 | 196 | 0.380 |
Why?
|
Cholestasis | 3 | 2007 | 378 | 0.360 |
Why?
|
Biopsy | 14 | 2020 | 6755 | 0.360 |
Why?
|
Female | 94 | 2022 | 380193 | 0.340 |
Why?
|
Humans | 151 | 2024 | 744366 | 0.340 |
Why?
|
Hemochromatosis | 3 | 2005 | 184 | 0.340 |
Why?
|
Recombinant Proteins | 15 | 2016 | 6621 | 0.320 |
Why?
|
Hepatitis C Antibodies | 5 | 2012 | 145 | 0.320 |
Why?
|
gamma-Glutamyltransferase | 4 | 2021 | 134 | 0.310 |
Why?
|
Hepatitis, Autoimmune | 3 | 2015 | 141 | 0.310 |
Why?
|
Drug Combinations | 4 | 2021 | 1958 | 0.310 |
Why?
|
Colitis, Ulcerative | 2 | 2017 | 1911 | 0.310 |
Why?
|
Male | 79 | 2021 | 350115 | 0.300 |
Why?
|
Growth Disorders | 1 | 2012 | 645 | 0.300 |
Why?
|
Liver Failure, Acute | 2 | 2006 | 165 | 0.290 |
Why?
|
Drug Therapy, Combination | 13 | 2024 | 6489 | 0.290 |
Why?
|
Portal Vein | 4 | 2022 | 437 | 0.280 |
Why?
|
Cholestasis, Intrahepatic | 3 | 1997 | 68 | 0.270 |
Why?
|
Pediatrics | 2 | 2020 | 3475 | 0.260 |
Why?
|
Mass Screening | 4 | 2018 | 5253 | 0.260 |
Why?
|
Hepatopulmonary Syndrome | 1 | 2005 | 20 | 0.260 |
Why?
|
Biliary Atresia | 1 | 2005 | 73 | 0.250 |
Why?
|
Cystic Fibrosis | 4 | 2018 | 1178 | 0.250 |
Why?
|
Ursodeoxycholic Acid | 3 | 2021 | 72 | 0.240 |
Why?
|
Treatment Outcome | 25 | 2024 | 63107 | 0.240 |
Why?
|
Benzopyrans | 1 | 2024 | 64 | 0.240 |
Why?
|
Drug Resistance, Viral | 4 | 2018 | 820 | 0.230 |
Why?
|
Hepatitis | 2 | 2017 | 227 | 0.230 |
Why?
|
Pregnancy | 12 | 2022 | 29144 | 0.230 |
Why?
|
Bilirubin | 3 | 2021 | 425 | 0.230 |
Why?
|
Body Composition | 2 | 2012 | 2402 | 0.230 |
Why?
|
Hemodynamics | 1 | 2014 | 4196 | 0.230 |
Why?
|
Predictive Value of Tests | 9 | 2018 | 15078 | 0.220 |
Why?
|
ROC Curve | 3 | 2020 | 3528 | 0.220 |
Why?
|
Hypopituitarism | 1 | 2005 | 254 | 0.220 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 2 | 1995 | 139 | 0.220 |
Why?
|
Early Diagnosis | 2 | 2020 | 1184 | 0.210 |
Why?
|
Immunoglobulins, Intravenous | 5 | 2001 | 652 | 0.210 |
Why?
|
Esophageal and Gastric Varices | 2 | 2019 | 207 | 0.210 |
Why?
|
Blood Transfusion | 2 | 2007 | 1301 | 0.210 |
Why?
|
Viral Hepatitis Vaccines | 4 | 2004 | 80 | 0.200 |
Why?
|
Ganciclovir | 1 | 2002 | 258 | 0.200 |
Why?
|
Indicator Dilution Techniques | 2 | 1999 | 40 | 0.200 |
Why?
|
Diltiazem | 1 | 2001 | 133 | 0.190 |
Why?
|
Cutis Laxa | 1 | 2000 | 29 | 0.190 |
Why?
|
Fibrosis | 3 | 2020 | 2029 | 0.190 |
Why?
|
Heart Defects, Congenital | 2 | 2015 | 4583 | 0.190 |
Why?
|
Interferon Type I | 2 | 1996 | 542 | 0.180 |
Why?
|
Disease Progression | 9 | 2021 | 13286 | 0.180 |
Why?
|
Body Mass Index | 4 | 2015 | 12721 | 0.180 |
Why?
|
Infant, Newborn | 18 | 2018 | 25628 | 0.180 |
Why?
|
Young Adult | 14 | 2019 | 56429 | 0.180 |
Why?
|
Hospitals, Pediatric | 3 | 2020 | 1775 | 0.180 |
Why?
|
Biliary Tract Diseases | 2 | 2017 | 161 | 0.170 |
Why?
|
Maternal-Fetal Exchange | 2 | 2020 | 456 | 0.170 |
Why?
|
Boston | 6 | 2021 | 9312 | 0.170 |
Why?
|
Uracil | 1 | 2020 | 165 | 0.170 |
Why?
|
Graves Disease | 1 | 2020 | 242 | 0.170 |
Why?
|
Hepatitis B Core Antigens | 3 | 2012 | 92 | 0.170 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2002 | 615 | 0.160 |
Why?
|
Cyclopropanes | 1 | 2020 | 416 | 0.160 |
Why?
|
Cardiac Output | 2 | 1999 | 854 | 0.160 |
Why?
|
Child Welfare | 1 | 2003 | 523 | 0.160 |
Why?
|
Lithium Chloride | 2 | 1999 | 87 | 0.160 |
Why?
|
Double-Blind Method | 5 | 2015 | 12025 | 0.160 |
Why?
|
Lactams, Macrocyclic | 1 | 2020 | 320 | 0.160 |
Why?
|
Uridine Monophosphate | 1 | 2018 | 70 | 0.160 |
Why?
|
Ritonavir | 1 | 2020 | 322 | 0.160 |
Why?
|
Proline | 1 | 2020 | 458 | 0.160 |
Why?
|
Capsule Endoscopy | 1 | 2019 | 125 | 0.160 |
Why?
|
Cat-Scratch Disease | 1 | 1997 | 23 | 0.160 |
Why?
|
Extracorporeal Membrane Oxygenation | 3 | 1999 | 1354 | 0.160 |
Why?
|
RNA, Viral | 8 | 2016 | 2901 | 0.160 |
Why?
|
Graft Survival | 5 | 2021 | 3737 | 0.150 |
Why?
|
Immunologic Deficiency Syndromes | 3 | 2001 | 547 | 0.150 |
Why?
|
Hepatitis, Chronic | 3 | 2004 | 52 | 0.150 |
Why?
|
Genotype | 8 | 2024 | 12952 | 0.150 |
Why?
|
Vancomycin | 1 | 2021 | 501 | 0.150 |
Why?
|
Minocycline | 1 | 1998 | 163 | 0.150 |
Why?
|
Biliary Tract | 1 | 1998 | 134 | 0.150 |
Why?
|
Anilides | 1 | 2020 | 408 | 0.150 |
Why?
|
Ibuprofen | 1 | 1998 | 236 | 0.140 |
Why?
|
Pressure | 1 | 2020 | 1203 | 0.140 |
Why?
|
Choledochostomy | 1 | 2016 | 15 | 0.140 |
Why?
|
Follow-Up Studies | 13 | 2020 | 39052 | 0.140 |
Why?
|
Liver Function Tests | 4 | 2019 | 528 | 0.130 |
Why?
|
Cytomegalovirus Infections | 1 | 2002 | 820 | 0.130 |
Why?
|
Carcinoma, Hepatocellular | 5 | 2019 | 2214 | 0.130 |
Why?
|
Drug Administration Schedule | 4 | 2017 | 4933 | 0.130 |
Why?
|
Common Variable Immunodeficiency | 1 | 1996 | 93 | 0.130 |
Why?
|
Hyalin | 1 | 2015 | 37 | 0.130 |
Why?
|
Retrospective Studies | 21 | 2023 | 77460 | 0.130 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 1995 | 245 | 0.130 |
Why?
|
Carrier State | 2 | 1990 | 518 | 0.130 |
Why?
|
Prevalence | 8 | 2018 | 15221 | 0.130 |
Why?
|
Stevens-Johnson Syndrome | 1 | 1998 | 281 | 0.130 |
Why?
|
Kupffer Cells | 1 | 2015 | 142 | 0.130 |
Why?
|
Immunization | 1 | 2019 | 1256 | 0.130 |
Why?
|
Urban Health | 1 | 1997 | 547 | 0.120 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 1996 | 214 | 0.120 |
Why?
|
Adult | 29 | 2024 | 214052 | 0.120 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 2019 | 1131 | 0.120 |
Why?
|
Tacrolimus | 3 | 2016 | 743 | 0.120 |
Why?
|
Cohort Studies | 9 | 2018 | 40559 | 0.110 |
Why?
|
Transplantation, Homologous | 2 | 2020 | 4777 | 0.110 |
Why?
|
Living Donors | 1 | 1998 | 621 | 0.110 |
Why?
|
Obesity | 3 | 2013 | 12746 | 0.110 |
Why?
|
Adolescent Health Services | 2 | 2007 | 215 | 0.110 |
Why?
|
Liver Neoplasms | 6 | 2019 | 4253 | 0.110 |
Why?
|
Organ Transplantation | 2 | 2021 | 1140 | 0.110 |
Why?
|
Portasystemic Shunt, Surgical | 2 | 2005 | 41 | 0.110 |
Why?
|
Hemodialysis Units, Hospital | 1 | 1992 | 22 | 0.110 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 1994 | 142 | 0.100 |
Why?
|
Liver Failure | 4 | 2012 | 241 | 0.100 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2017 | 10943 | 0.100 |
Why?
|
Dyslipidemias | 1 | 2019 | 849 | 0.100 |
Why?
|
Diarrhea, Infantile | 1 | 1991 | 109 | 0.100 |
Why?
|
Hepatoblastoma | 2 | 2010 | 87 | 0.100 |
Why?
|
Risk Factors | 12 | 2023 | 72296 | 0.100 |
Why?
|
Risk Adjustment | 1 | 2015 | 594 | 0.100 |
Why?
|
Adipokines | 1 | 2013 | 320 | 0.100 |
Why?
|
Lectins | 1 | 2013 | 513 | 0.090 |
Why?
|
Immunization Schedule | 2 | 2003 | 221 | 0.090 |
Why?
|
Glomerulonephritis, Membranous | 1 | 1991 | 86 | 0.090 |
Why?
|
Diet, Fat-Restricted | 1 | 2013 | 320 | 0.090 |
Why?
|
Primary Health Care | 1 | 2007 | 4557 | 0.090 |
Why?
|
Registries | 3 | 2021 | 8091 | 0.090 |
Why?
|
Graft Rejection | 3 | 2021 | 4397 | 0.090 |
Why?
|
Acute Disease | 3 | 2015 | 7147 | 0.090 |
Why?
|
Hyaluronic Acid | 1 | 2013 | 491 | 0.090 |
Why?
|
Quality Improvement | 2 | 2023 | 3749 | 0.090 |
Why?
|
Biopsy, Needle | 2 | 2013 | 1641 | 0.090 |
Why?
|
Prospective Studies | 9 | 2020 | 53290 | 0.080 |
Why?
|
Clinical Trials as Topic | 3 | 2020 | 7914 | 0.080 |
Why?
|
Multivariate Analysis | 3 | 2014 | 12244 | 0.080 |
Why?
|
Area Under Curve | 1 | 2013 | 1655 | 0.080 |
Why?
|
Propylthiouracil | 1 | 1988 | 69 | 0.080 |
Why?
|
Aspartate Aminotransferases | 2 | 2021 | 418 | 0.080 |
Why?
|
Adiponectin | 1 | 2015 | 1101 | 0.080 |
Why?
|
Intestinal Pseudo-Obstruction | 1 | 1988 | 48 | 0.080 |
Why?
|
Viremia | 3 | 2016 | 736 | 0.080 |
Why?
|
Hospitals | 1 | 2022 | 3954 | 0.080 |
Why?
|
Severity of Illness Index | 4 | 2020 | 15535 | 0.080 |
Why?
|
Disease Transmission, Infectious | 2 | 2007 | 547 | 0.080 |
Why?
|
Digestive System Neoplasms | 1 | 2008 | 86 | 0.080 |
Why?
|
Administration, Oral | 3 | 2021 | 3914 | 0.080 |
Why?
|
Decision Trees | 1 | 2020 | 506 | 0.080 |
Why?
|
Behavior | 1 | 2011 | 561 | 0.080 |
Why?
|
Drug Contamination | 3 | 2001 | 147 | 0.080 |
Why?
|
Serum Albumin | 2 | 2021 | 675 | 0.080 |
Why?
|
Placebos | 1 | 2012 | 1676 | 0.080 |
Why?
|
Thalassemia | 1 | 2008 | 273 | 0.080 |
Why?
|
Alagille Syndrome | 1 | 2007 | 35 | 0.070 |
Why?
|
Biliary Tract Surgical Procedures | 1 | 2007 | 47 | 0.070 |
Why?
|
Deferoxamine | 1 | 1987 | 151 | 0.070 |
Why?
|
Rifamycins | 1 | 2006 | 25 | 0.070 |
Why?
|
Lactulose | 1 | 2006 | 33 | 0.070 |
Why?
|
Chromosome Mapping | 1 | 1995 | 4740 | 0.070 |
Why?
|
Interferons | 2 | 2001 | 706 | 0.070 |
Why?
|
Autoantibodies | 2 | 2013 | 2036 | 0.070 |
Why?
|
Vena Cava, Inferior | 1 | 2010 | 440 | 0.070 |
Why?
|
Drug Tolerance | 1 | 2008 | 376 | 0.070 |
Why?
|
Research Design | 1 | 2002 | 5984 | 0.070 |
Why?
|
Time Factors | 6 | 2021 | 40075 | 0.070 |
Why?
|
Gene Products, pol | 1 | 2006 | 47 | 0.070 |
Why?
|
Animal Population Groups | 1 | 1985 | 12 | 0.070 |
Why?
|
Galactosidases | 1 | 1985 | 56 | 0.070 |
Why?
|
Animals, Suckling | 1 | 1985 | 72 | 0.070 |
Why?
|
Pregnancy Complications | 1 | 2020 | 2861 | 0.070 |
Why?
|
Bile Ducts, Extrahepatic | 1 | 2005 | 49 | 0.070 |
Why?
|
Hepatic Encephalopathy | 1 | 2006 | 139 | 0.070 |
Why?
|
Eating | 1 | 2012 | 1536 | 0.060 |
Why?
|
Recurrence | 3 | 2021 | 8340 | 0.060 |
Why?
|
Ultrasonography, Interventional | 1 | 2013 | 1486 | 0.060 |
Why?
|
Scleroderma, Systemic | 1 | 1988 | 323 | 0.060 |
Why?
|
Ileum | 1 | 2007 | 565 | 0.060 |
Why?
|
Cross-Sectional Studies | 5 | 2018 | 25039 | 0.060 |
Why?
|
Seroepidemiologic Studies | 2 | 2019 | 402 | 0.060 |
Why?
|
Longitudinal Studies | 3 | 2016 | 13991 | 0.060 |
Why?
|
beta-Galactosidase | 1 | 1985 | 574 | 0.060 |
Why?
|
Heart | 1 | 1998 | 4464 | 0.060 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2007 | 437 | 0.060 |
Why?
|
Postoperative Complications | 4 | 2016 | 15297 | 0.060 |
Why?
|
Cardiac Surgical Procedures | 1 | 1999 | 3537 | 0.060 |
Why?
|
Stents | 1 | 2016 | 3282 | 0.060 |
Why?
|
Crohn Disease | 1 | 2017 | 2304 | 0.060 |
Why?
|
Muscular Diseases | 1 | 1988 | 555 | 0.060 |
Why?
|
Iron | 3 | 2008 | 1774 | 0.060 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 3255 | 0.060 |
Why?
|
Hepatitis B Antibodies | 1 | 2004 | 159 | 0.060 |
Why?
|
Body Weight | 2 | 2012 | 4671 | 0.060 |
Why?
|
Linear Models | 1 | 2014 | 5953 | 0.060 |
Why?
|
Child Behavior | 1 | 2009 | 839 | 0.060 |
Why?
|
Amlodipine | 1 | 2023 | 83 | 0.050 |
Why?
|
Cognition | 2 | 2011 | 6770 | 0.050 |
Why?
|
Serologic Tests | 2 | 1998 | 374 | 0.050 |
Why?
|
Age Factors | 4 | 2021 | 18373 | 0.050 |
Why?
|
Gastrointestinal Agents | 1 | 2006 | 494 | 0.050 |
Why?
|
Lipids | 1 | 2013 | 3307 | 0.050 |
Why?
|
Insulin Resistance | 2 | 2013 | 3864 | 0.050 |
Why?
|
Weight Loss | 1 | 2013 | 2625 | 0.050 |
Why?
|
Prognosis | 6 | 2020 | 29060 | 0.050 |
Why?
|
Morbidity | 1 | 2007 | 1768 | 0.050 |
Why?
|
Neutropenia | 2 | 2010 | 895 | 0.050 |
Why?
|
Immunoglobulin G | 2 | 2015 | 4561 | 0.050 |
Why?
|
Egypt | 1 | 2020 | 100 | 0.050 |
Why?
|
Antibodies, Monoclonal | 2 | 2008 | 9274 | 0.050 |
Why?
|
Autoimmune Diseases | 1 | 2013 | 2134 | 0.050 |
Why?
|
Florida | 2 | 2012 | 435 | 0.050 |
Why?
|
Intestines | 2 | 1991 | 1924 | 0.050 |
Why?
|
2-Naphthylamine | 1 | 2020 | 23 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14723 | 0.050 |
Why?
|
DNA Mutational Analysis | 2 | 2007 | 4185 | 0.050 |
Why?
|
Cholangiography | 1 | 2020 | 189 | 0.050 |
Why?
|
Breast Feeding | 1 | 2009 | 1338 | 0.050 |
Why?
|
Inflammation | 1 | 2020 | 10637 | 0.050 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1989 | 2232 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 1998 | 7182 | 0.050 |
Why?
|
Causality | 1 | 2007 | 1275 | 0.050 |
Why?
|
Glycoproteins | 1 | 2008 | 2266 | 0.050 |
Why?
|
Tablets | 1 | 2020 | 145 | 0.040 |
Why?
|
Vaccination | 2 | 2009 | 3279 | 0.040 |
Why?
|
Digestive System | 1 | 2000 | 253 | 0.040 |
Why?
|
Thrombosis | 2 | 2010 | 2968 | 0.040 |
Why?
|
United States | 8 | 2021 | 69872 | 0.040 |
Why?
|
Administration, Topical | 1 | 2001 | 690 | 0.040 |
Why?
|
Infectious Disease Transmission, Professional-to-Patient | 1 | 2019 | 35 | 0.040 |
Why?
|
Incidence | 4 | 2013 | 20952 | 0.040 |
Why?
|
Emotions | 1 | 2011 | 2659 | 0.040 |
Why?
|
Manometry | 1 | 2001 | 445 | 0.040 |
Why?
|
Penicillamine | 1 | 1998 | 59 | 0.040 |
Why?
|
Phenotype | 1 | 2016 | 16367 | 0.040 |
Why?
|
Anorexia Nervosa | 1 | 2008 | 1286 | 0.040 |
Why?
|
Sample Size | 1 | 2002 | 845 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2015 | 9955 | 0.040 |
Why?
|
Hepatolenticular Degeneration | 1 | 1998 | 69 | 0.040 |
Why?
|
Quality of Life | 2 | 2011 | 12802 | 0.040 |
Why?
|
Blood Glucose | 1 | 2013 | 6254 | 0.040 |
Why?
|
Chorion | 1 | 1998 | 117 | 0.040 |
Why?
|
Urethra | 1 | 2000 | 408 | 0.040 |
Why?
|
Valine | 1 | 2020 | 413 | 0.040 |
Why?
|
Patient Selection | 1 | 2010 | 4216 | 0.040 |
Why?
|
Massachusetts | 3 | 2015 | 8662 | 0.040 |
Why?
|
Anal Canal | 1 | 2001 | 376 | 0.040 |
Why?
|
Platelet Count | 1 | 2020 | 780 | 0.040 |
Why?
|
Survival Analysis | 3 | 2008 | 10252 | 0.040 |
Why?
|
Blood Group Incompatibility | 1 | 1999 | 146 | 0.040 |
Why?
|
Harm Reduction | 1 | 2019 | 129 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2016 | 9240 | 0.040 |
Why?
|
Random Allocation | 1 | 2002 | 2428 | 0.040 |
Why?
|
Streptococcus | 1 | 1997 | 197 | 0.040 |
Why?
|
Galactosemias | 1 | 1998 | 125 | 0.040 |
Why?
|
Hip Fractures | 1 | 2005 | 955 | 0.040 |
Why?
|
Kidney | 3 | 2023 | 7184 | 0.040 |
Why?
|
Chelating Agents | 1 | 1998 | 380 | 0.040 |
Why?
|
Caregivers | 1 | 2009 | 2095 | 0.040 |
Why?
|
Amnion | 1 | 1998 | 209 | 0.040 |
Why?
|
Chronic Disease | 3 | 2001 | 9145 | 0.040 |
Why?
|
Thyroxine | 1 | 2020 | 667 | 0.040 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 1991 | 3338 | 0.040 |
Why?
|
Burkholderia cepacia | 1 | 1996 | 22 | 0.040 |
Why?
|
Hepatitis D | 1 | 1996 | 18 | 0.040 |
Why?
|
Streptococcus agalactiae | 1 | 1998 | 375 | 0.040 |
Why?
|
ABO Blood-Group System | 1 | 1999 | 367 | 0.040 |
Why?
|
Hepatitis B Antigens | 1 | 2015 | 40 | 0.030 |
Why?
|
Venous Thrombosis | 1 | 2005 | 1239 | 0.030 |
Why?
|
Peptides | 1 | 2008 | 4410 | 0.030 |
Why?
|
Internationality | 1 | 2021 | 1002 | 0.030 |
Why?
|
Intestinal Mucosa | 2 | 2001 | 3037 | 0.030 |
Why?
|
Microscopy, Electron | 4 | 2001 | 2646 | 0.030 |
Why?
|
Streptococcus pyogenes | 1 | 1998 | 289 | 0.030 |
Why?
|
Blood Component Transfusion | 1 | 1996 | 143 | 0.030 |
Why?
|
Drug Resistance | 1 | 2021 | 1608 | 0.030 |
Why?
|
Models, Statistical | 1 | 2010 | 5101 | 0.030 |
Why?
|
Bile Acids and Salts | 1 | 1997 | 368 | 0.030 |
Why?
|
Metabolism, Inborn Errors | 1 | 1997 | 288 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2023 | 2166 | 0.030 |
Why?
|
Oxidoreductases | 1 | 1997 | 424 | 0.030 |
Why?
|
Thyroidectomy | 1 | 2020 | 879 | 0.030 |
Why?
|
Isoniazid | 1 | 1996 | 274 | 0.030 |
Why?
|
Risk Assessment | 4 | 2017 | 23336 | 0.030 |
Why?
|
Tissue Donors | 2 | 2016 | 2241 | 0.030 |
Why?
|
Kidney Transplantation | 1 | 2010 | 4251 | 0.030 |
Why?
|
Nephrotic Syndrome | 1 | 1998 | 389 | 0.030 |
Why?
|
Liver Regeneration | 1 | 1996 | 210 | 0.030 |
Why?
|
Mitochondrial Proteins | 1 | 2020 | 994 | 0.030 |
Why?
|
Urinary Bladder | 1 | 2000 | 1173 | 0.030 |
Why?
|
Radiography, Thoracic | 1 | 2000 | 1265 | 0.030 |
Why?
|
Practice Guidelines as Topic | 3 | 2019 | 7282 | 0.030 |
Why?
|
Acne Vulgaris | 1 | 1998 | 302 | 0.030 |
Why?
|
Bile Ducts | 2 | 2010 | 284 | 0.030 |
Why?
|
Propensity Score | 1 | 2021 | 1781 | 0.030 |
Why?
|
Inclusion Bodies | 1 | 2015 | 279 | 0.030 |
Why?
|
Blood Flow Velocity | 1 | 1998 | 1423 | 0.030 |
Why?
|
School Health Services | 1 | 1997 | 375 | 0.030 |
Why?
|
Stress, Psychological | 1 | 2009 | 4245 | 0.030 |
Why?
|
Prednisone | 1 | 1998 | 1574 | 0.030 |
Why?
|
Keratinocytes | 1 | 1998 | 799 | 0.030 |
Why?
|
Middle Aged | 10 | 2015 | 213390 | 0.030 |
Why?
|
Giant Cells | 1 | 1994 | 187 | 0.030 |
Why?
|
Respiratory System | 1 | 1996 | 557 | 0.030 |
Why?
|
Drug Resistance, Multiple, Viral | 1 | 2013 | 52 | 0.030 |
Why?
|
Microcirculation | 1 | 1997 | 1287 | 0.030 |
Why?
|
Bone Marrow Cells | 1 | 2001 | 2513 | 0.030 |
Why?
|
Kidney Diseases, Cystic | 1 | 1994 | 186 | 0.030 |
Why?
|
Hepatectomy | 1 | 1996 | 550 | 0.030 |
Why?
|
Substance Abuse, Intravenous | 1 | 1997 | 525 | 0.030 |
Why?
|
Models, Cardiovascular | 1 | 1998 | 996 | 0.030 |
Why?
|
Hepatitis Antibodies | 1 | 1992 | 73 | 0.030 |
Why?
|
Infectious Disease Medicine | 1 | 2012 | 46 | 0.030 |
Why?
|
Splenic Vein | 1 | 1991 | 31 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 1998 | 2887 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2021 | 2108 | 0.030 |
Why?
|
Risk-Taking | 1 | 1997 | 986 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2007 | 12961 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 1998 | 35425 | 0.020 |
Why?
|
Pain Measurement | 1 | 2001 | 3420 | 0.020 |
Why?
|
Sexually Transmitted Diseases | 1 | 1997 | 623 | 0.020 |
Why?
|
Spleen | 1 | 1997 | 2362 | 0.020 |
Why?
|
Immunosuppressive Agents | 2 | 2016 | 4153 | 0.020 |
Why?
|
Subcutaneous Emphysema | 1 | 1990 | 16 | 0.020 |
Why?
|
Nutrition Disorders | 1 | 1991 | 211 | 0.020 |
Why?
|
Glycemic Index | 1 | 2013 | 394 | 0.020 |
Why?
|
Pneumatosis Cystoides Intestinalis | 1 | 1990 | 31 | 0.020 |
Why?
|
Wound Healing | 1 | 2001 | 2785 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 1996 | 6171 | 0.020 |
Why?
|
Counseling | 1 | 2018 | 1523 | 0.020 |
Why?
|
Hospitalization | 2 | 2006 | 10259 | 0.020 |
Why?
|
Diet, Reducing | 1 | 2013 | 462 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2019 | 5077 | 0.020 |
Why?
|
AIDS-Related Complex | 1 | 1989 | 110 | 0.020 |
Why?
|
Logistic Models | 2 | 2002 | 13409 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 4 | 2010 | 20130 | 0.020 |
Why?
|
Algorithms | 1 | 2020 | 13882 | 0.020 |
Why?
|
Haplotypes | 1 | 1995 | 2779 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1996 | 3873 | 0.020 |
Why?
|
Catheters, Indwelling | 1 | 1991 | 426 | 0.020 |
Why?
|
Cysts | 1 | 1994 | 678 | 0.020 |
Why?
|
Legal Guardians | 1 | 2009 | 56 | 0.020 |
Why?
|
Fatal Outcome | 1 | 1994 | 1851 | 0.020 |
Why?
|
Brain Death | 1 | 2012 | 348 | 0.020 |
Why?
|
Adolescent Behavior | 1 | 1997 | 1151 | 0.020 |
Why?
|
Escherichia coli | 1 | 2001 | 4217 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2015 | 11366 | 0.020 |
Why?
|
Antitubercular Agents | 1 | 1996 | 1320 | 0.020 |
Why?
|
Viral Load | 1 | 2017 | 3300 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2001 | 3390 | 0.020 |
Why?
|
Dietary Carbohydrates | 1 | 2013 | 905 | 0.020 |
Why?
|
Antibodies | 1 | 1996 | 2460 | 0.020 |
Why?
|
Intra-Abdominal Fat | 1 | 2013 | 591 | 0.020 |
Why?
|
Mothers | 1 | 2018 | 2165 | 0.020 |
Why?
|
Sickness Impact Profile | 1 | 2009 | 302 | 0.020 |
Why?
|
Sexual Behavior | 1 | 1997 | 2055 | 0.020 |
Why?
|
Immunization, Passive | 1 | 1990 | 623 | 0.020 |
Why?
|
Sweat | 1 | 2007 | 49 | 0.020 |
Why?
|
Emphysema | 1 | 1990 | 247 | 0.020 |
Why?
|
Ultrasonography | 1 | 2000 | 5984 | 0.020 |
Why?
|
Peroxisome Proliferator-Activated Receptors | 1 | 2007 | 64 | 0.020 |
Why?
|
Intestinal Diseases | 1 | 2012 | 530 | 0.020 |
Why?
|
Hybridomas | 1 | 2008 | 452 | 0.020 |
Why?
|
Isoproterenol | 1 | 2007 | 399 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 1998 | 4424 | 0.020 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2007 | 101 | 0.020 |
Why?
|
Pneumonia | 1 | 1998 | 2133 | 0.020 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2021 | 2428 | 0.020 |
Why?
|
Bacterial Adhesion | 2 | 1998 | 316 | 0.020 |
Why?
|
Ion Transport | 1 | 2007 | 320 | 0.020 |
Why?
|
Disease Outbreaks | 1 | 1996 | 1771 | 0.020 |
Why?
|
Splenorenal Shunt, Surgical | 1 | 2005 | 14 | 0.020 |
Why?
|
Models, Anatomic | 1 | 2010 | 691 | 0.020 |
Why?
|
Sucrase | 1 | 1985 | 54 | 0.020 |
Why?
|
Colon | 1 | 1994 | 1772 | 0.020 |
Why?
|
Intestine, Small | 1 | 2012 | 1240 | 0.020 |
Why?
|
Blood Pressure | 1 | 2001 | 8551 | 0.020 |
Why?
|
Health Behavior | 1 | 1997 | 2635 | 0.020 |
Why?
|
Nutrition Surveys | 1 | 2012 | 1660 | 0.020 |
Why?
|
Weaning | 1 | 1985 | 105 | 0.020 |
Why?
|
Cells, Cultured | 4 | 2008 | 19233 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 1997 | 4459 | 0.020 |
Why?
|
Microvilli | 1 | 1985 | 241 | 0.020 |
Why?
|
Tritium | 1 | 1985 | 745 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2008 | 13693 | 0.020 |
Why?
|
Pancreas | 1 | 1991 | 1687 | 0.020 |
Why?
|
Heart Diseases | 1 | 1998 | 2789 | 0.020 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2007 | 504 | 0.020 |
Why?
|
Alleles | 1 | 1995 | 6933 | 0.020 |
Why?
|
Sampling Studies | 1 | 2005 | 623 | 0.010 |
Why?
|
Tissue and Organ Procurement | 1 | 2012 | 896 | 0.010 |
Why?
|
Leucine | 1 | 1985 | 560 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2020 | 7882 | 0.010 |
Why?
|
Ultrasonography, Doppler | 1 | 2005 | 458 | 0.010 |
Why?
|
Germany | 1 | 2005 | 862 | 0.010 |
Why?
|
Adiposity | 1 | 2013 | 1806 | 0.010 |
Why?
|
Safety | 1 | 2008 | 1186 | 0.010 |
Why?
|
Reoperation | 2 | 1993 | 4201 | 0.010 |
Why?
|
Aged, 80 and over | 3 | 2005 | 57776 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1985 | 1801 | 0.010 |
Why?
|
Environmental Exposure | 1 | 1997 | 4232 | 0.010 |
Why?
|
Epithelium | 2 | 1998 | 1679 | 0.010 |
Why?
|
Probability | 1 | 2008 | 2506 | 0.010 |
Why?
|
Child Nutritional Physiological Phenomena | 1 | 2004 | 303 | 0.010 |
Why?
|
Aorta | 1 | 2010 | 2062 | 0.010 |
Why?
|
Health Surveys | 1 | 2012 | 4036 | 0.010 |
Why?
|
Computer Simulation | 1 | 1995 | 6194 | 0.010 |
Why?
|
Hepatocytes | 1 | 2008 | 1211 | 0.010 |
Why?
|
Cytochalasin D | 1 | 2001 | 92 | 0.010 |
Why?
|
Annexin A5 | 1 | 2001 | 103 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 2006 | 1680 | 0.010 |
Why?
|
Canada | 1 | 2006 | 2065 | 0.010 |
Why?
|
Risk | 2 | 1996 | 9688 | 0.010 |
Why?
|
Colony-Forming Units Assay | 1 | 2001 | 356 | 0.010 |
Why?
|
Myeloid Progenitor Cells | 1 | 2001 | 111 | 0.010 |
Why?
|
Sex Distribution | 1 | 2005 | 2297 | 0.010 |
Why?
|
Caco-2 Cells | 1 | 2001 | 387 | 0.010 |
Why?
|
Angiography | 1 | 2005 | 1639 | 0.010 |
Why?
|
Needs Assessment | 1 | 2006 | 1147 | 0.010 |
Why?
|
Colchicine | 1 | 2001 | 244 | 0.010 |
Why?
|
Age Distribution | 1 | 2005 | 2902 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 1998 | 19905 | 0.010 |
Why?
|
Nutritional Status | 1 | 2008 | 1609 | 0.010 |
Why?
|
Micromonosporaceae | 1 | 1998 | 1 | 0.010 |
Why?
|
Patient Compliance | 1 | 1990 | 2684 | 0.010 |
Why?
|
Trientine | 1 | 1998 | 11 | 0.010 |
Why?
|
Kidney Failure, Chronic | 1 | 1992 | 2535 | 0.010 |
Why?
|
Periodicity | 1 | 2001 | 364 | 0.010 |
Why?
|
Public Health | 1 | 2012 | 2602 | 0.010 |
Why?
|
Apolipoproteins C | 1 | 1998 | 59 | 0.010 |
Why?
|
Family | 1 | 1990 | 3147 | 0.010 |
Why?
|
Antigens, CD34 | 1 | 2001 | 659 | 0.010 |
Why?
|
Stomach Neoplasms | 1 | 2008 | 1332 | 0.010 |
Why?
|
Apoptosis | 2 | 2008 | 9724 | 0.010 |
Why?
|
Hemosiderosis | 1 | 1998 | 71 | 0.010 |
Why?
|
Aged | 5 | 2005 | 163288 | 0.010 |
Why?
|
Spectrometry, Mass, Fast Atom Bombardment | 1 | 1997 | 31 | 0.010 |
Why?
|
Cholic Acids | 1 | 1997 | 41 | 0.010 |
Why?
|
Gastroenterology | 1 | 2004 | 538 | 0.010 |
Why?
|
Culture Techniques | 1 | 1998 | 554 | 0.010 |
Why?
|
Lymphocytosis | 1 | 1998 | 119 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 1985 | 2126 | 0.010 |
Why?
|
Cholic Acid | 1 | 1997 | 34 | 0.010 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2001 | 648 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2008 | 6896 | 0.010 |
Why?
|
Antigens, CD | 1 | 2008 | 4026 | 0.010 |
Why?
|
Sepsis | 1 | 1991 | 2593 | 0.010 |
Why?
|
Administration, Intranasal | 1 | 1998 | 446 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2008 | 6539 | 0.010 |
Why?
|
Radiography | 1 | 1988 | 7023 | 0.010 |
Why?
|
Neutrophils | 2 | 2001 | 3721 | 0.010 |
Why?
|
Galactose | 1 | 1998 | 306 | 0.010 |
Why?
|
Retreatment | 1 | 1998 | 610 | 0.010 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 1998 | 279 | 0.010 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 1997 | 361 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2009 | 3531 | 0.010 |
Why?
|
Models, Biological | 1 | 1993 | 9584 | 0.010 |
Why?
|
Burkholderia Infections | 1 | 1996 | 44 | 0.010 |
Why?
|
Survival Rate | 2 | 2005 | 12788 | 0.010 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 1998 | 595 | 0.010 |
Why?
|
Family Health | 1 | 2001 | 1281 | 0.010 |
Why?
|
Research | 1 | 2004 | 1999 | 0.010 |
Why?
|
Parents | 1 | 2009 | 3405 | 0.010 |
Why?
|
Caroli Disease | 1 | 1994 | 12 | 0.010 |
Why?
|
Microtubules | 1 | 2001 | 1089 | 0.010 |
Why?
|
Rifampin | 1 | 1996 | 315 | 0.010 |
Why?
|
Polycystic Kidney, Autosomal Recessive | 1 | 1994 | 32 | 0.010 |
Why?
|
Cell Line | 2 | 2001 | 16000 | 0.010 |
Why?
|
New York City | 1 | 1996 | 710 | 0.010 |
Why?
|
Biological Transport | 1 | 1998 | 2120 | 0.010 |
Why?
|
Pilot Projects | 1 | 2006 | 8319 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 1996 | 1799 | 0.010 |
Why?
|
Length of Stay | 1 | 2006 | 6311 | 0.010 |
Why?
|
Polycystic Kidney, Autosomal Dominant | 1 | 1994 | 168 | 0.010 |
Why?
|
Cell Division | 1 | 2001 | 4569 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2001 | 1678 | 0.010 |
Why?
|
Lidocaine | 1 | 1996 | 544 | 0.010 |
Why?
|
Antigens, Bacterial | 1 | 1998 | 1172 | 0.010 |
Why?
|
Health Status | 1 | 2006 | 4034 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2008 | 10483 | 0.010 |
Why?
|
Societies, Medical | 1 | 2004 | 3743 | 0.010 |
Why?
|
Mathematics | 1 | 1993 | 728 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2008 | 16690 | 0.010 |
Why?
|
Cytoskeleton | 1 | 1996 | 1185 | 0.010 |
Why?
|
Hematopoiesis | 1 | 2001 | 2073 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 1998 | 2216 | 0.010 |
Why?
|
Databases, Factual | 1 | 2006 | 7730 | 0.010 |
Why?
|
Cell Survival | 1 | 2001 | 5882 | 0.010 |
Why?
|
Lymphocytes | 1 | 1998 | 2617 | 0.010 |
Why?
|
Pancreatic Neoplasms | 1 | 2008 | 5263 | 0.010 |
Why?
|
New England | 1 | 1993 | 1022 | 0.010 |
Why?
|
Splenectomy | 1 | 1991 | 395 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 1998 | 3773 | 0.010 |
Why?
|
Rats | 1 | 1985 | 24252 | 0.010 |
Why?
|
Animals | 4 | 2001 | 168768 | 0.000 |
Why?
|
Chemotherapy, Adjuvant | 1 | 1996 | 3480 | 0.000 |
Why?
|
Promoter Regions, Genetic | 1 | 1998 | 5867 | 0.000 |
Why?
|
Stomach | 1 | 1991 | 697 | 0.000 |
Why?
|
Mice, Transgenic | 1 | 1998 | 9735 | 0.000 |
Why?
|
Combined Modality Therapy | 1 | 1996 | 8642 | 0.000 |
Why?
|
Mice, Knockout | 1 | 1998 | 14561 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 1998 | 21833 | 0.000 |
Why?
|
Cell Differentiation | 1 | 1998 | 11486 | 0.000 |
Why?
|
Lung | 1 | 1998 | 9857 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 1994 | 18034 | 0.000 |
Why?
|
Mice | 1 | 1998 | 81201 | 0.000 |
Why?
|
Brain | 1 | 1997 | 26388 | 0.000 |
Why?
|